NORMA eResearch @NCI Library

Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review

Longo, C.J, Fitch, Margaret I., Banfield, Laura E., Hanly, Paul, Yabroff, Karen Robin and Sharp, Linda (2020) Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Supportive Care in Cancer, 28 (10). pp. 4645-4665. ISSN 1433-7339

Full text not available from this repository.
Official URL: https://doi.org/10.1007/s00520-020-05620-9

Abstract

Purpose: Financial toxicity related to cancer diagnosis and treatment is a common issue in developed countries. We seek to systematically summarize the extent of the issue in very high development index countries with publicly funded healthcare. Methods: We identified articles published Jan 1, 2005, to March 7, 2019, describing financial burden/toxicity experienced by cancer patients and/or informal caregivers using OVID Medline Embase and PsychInfo, CINAHL, Business Source Complete, and EconLit databases. Only English language peer-reviewed full papers describing studies conducted in very high development index countries with predominantly publicly funded healthcare were eligible (excluded the USA). All stages of the review were evaluated in teams of two researchers excepting the final data extraction (CJL only). Results: The searches identified 7117 unique articles, 32 of which were eligible. Studies were undertaken in Canada, Australia, Ireland, UK, Germany, Denmark, Malaysia, Finland, France, South Korea, and the Netherlands. Eighteen studies reported patient/caregiver out-of-pocket costs (range US$17–US$506/month), 18 studies reported patient/caregiver lost income (range 17.6–67.3%), 14 studies reported patient/caregiver travel and accommodation costs (range US$8–US$393/month), and 6 studies reported financial stress (range 41–48%), strain (range 7–39%), or financial burden/distress/toxicity among patients/caregivers (range 22–27%). The majority of studies focused on patients, with some including caregivers. Financial toxicity was greater in those with early disease and/or more severe cancers. Conclusions: Despite government-funded universal public healthcare, financial toxicity is an issue for cancer patients and their families. Although levels of toxicity vary between countries, the findings suggest financial protection appears to be inadequate in many countries.

Item Type: Article
Subjects: H Social Sciences > H Social Sciences (General)
H Social Sciences > Economics
R Medicine > Healthcare Industry
Divisions: School of Business > Staff Research and Publications
Related URLs:
Depositing User: Dan English
Date Deposited: 26 Nov 2020 11:56
Last Modified: 26 Nov 2020 12:50
URI: http://norma.ncirl.ie/id/eprint/4357

Actions (login required)

View Item View Item